Medicare Enrolled

Dr. David Vesole, MD

Hematology · Hackensack, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
92 2ND ST, Hackensack, NJ 07601
5519968704
In practice since 2005 (20 years)
NPI: 1790773356 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vesole from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vesole? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vesole

Dr. David Vesole is a hematology specialist in Hackensack, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vesole performed 2,952 Medicare services across 472 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vesole received a total of $824,108 from 24 pharmaceutical and/or device companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vesole is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 2,952 Medicare services $824,108 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,952
Medicare services
Bottom 47% in NJ for hematology
472
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~148 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
1,920 $6 $39
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
745 $148 $301
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
194 $109 $239
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
50 $13 $74
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $79 $152
New patient office visit, complex (60-74 min) 12 $158 $442
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $116 $353
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$824,108
Total received (2018-2024)
Avg $117,730/year across 7 years
Top 8% in NJ for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
702
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$735,821 (89.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$87,038 (10.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,249 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$93,297
2023
$103,129
2022
$159,662
2021
$97,648
2020
$91,824
2019
$155,487
2018
$123,061

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$55,682
GENZYME CORPORATION
$15,537
Karyopharm Therapeutics Inc.
$13,125
Amgen Inc.
$4,021
E.R. Squibb & Sons, L.L.C.
$2,664
Takeda Pharmaceuticals U.S.A., Inc.
$1,860
Legend Biotech USA Inc.
$156
Celgene Corporation
$146
Novartis Pharmaceuticals Corporation
$45
SANOFI-AVENTIS U.S. LLC
$43
ABBVIE INC.
$17
Top 3 companies account for 90.4% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$220,136
Janssen Biotech, Inc.
$199,789
Amgen Inc.
$107,039
GlaxoSmithKline, LLC.
$101,072
GENZYME CORPORATION
$73,792
Karyopharm Therapeutics Inc.
$44,315
E.R. Squibb & Sons, L.L.C.
$39,645
Celgene Corporation
$12,829
Janssen Pharmaceuticals, Inc
$6,135
Pfizer Inc.
$6,000
AbbVie, Inc.
$4,376
Omeros Corporation
$3,800
Secura Bio, Inc.
$3,352
MENARINI SILICON BIOSYSTEMS, INC.
$500
BeiGene, Ltd.
$450
Legend Biotech USA Inc.
$235
Novartis Pharmaceuticals Corporation
$195
Pharmacyclics LLC, An AbbVie Company
$148
PFIZER INC.
$126
Astellas Pharma US Inc
$75
SANOFI-AVENTIS U.S. LLC
$43
Pharmacyclics LLC, an AbbVie Company
$23
ABBVIE INC.
$17
The Binding Site Inc.
$15
Top 3 companies account for 63.9% of all-time payments
Associated products mentioned in payments ›
BLENREP · BRUKINSA · CD38 · Cellsearch · DARZALEX · EMPLICITI · EPKINLY · Erleada · FARYDAK · FREELITE · IMBRUVICA · Kyprolis · MOZOBIL · NINLARO · NO PRODUCT DISCUSSED · Nplate · ONUREG · Pomalyst · REBLOZYL · REZUROCK · Revlimid · SARCLISA · SCEMBLIX · TECVAYLI · VELCADE · Venclexta · XGEVA · XPOVIO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for hematology in NJ.

Looking for a hematology specialist in Hackensack?
Compare hematologists in the Hackensack area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists within 10 mi
132
Per 100K population
13.8
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vesole is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vesole experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. Vesole performed 1,920 epoetin alfa injection (procrit) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vesole receive payments from pharmaceutical companies?
Yes. Dr. Vesole received a total of $824,108 from 24 companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vesole's costs compare to other hematologists in Hackensack?
Dr. Vesole's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vesole) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →